Zhytomyr, Ukraine Clinical Trials

A listing of Zhytomyr, Ukraine clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).

prednisone
mycophenolate
methotrexate
corticosteroids
myositis
Private Small Scale Medical Center Pulse
 (70.8 away) Contact site
  • 247 views
  • 01 Nov, 2020
  • +251 other locations
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

The proposed study is a randomized, double-blind,placebo-controlled, multi-center phase II study to investigatethe safety and efficacy of SHR0302 in patients with moderate to severe activeulcerative colitis. The study aims to evaluate the optimal dose of SHR0302 andtime needed in inducing clinical response in active ulcerative colitispatients. This is an 8+8 …

endoscopy
CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM
 (70.8 away) Contact site
  • 92 views
  • 19 Nov, 2020
  • +106 other locations
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

The purpose of this study is to assess the efficacy and safety of treatment with olaparib (MK-7339) in combination with pembrolizumab (MK-3475) in adults with previously treated, advanced (metastatic and/or unresectable) Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-positive solid tumors.

advanced cancer
mk-3475
cancer
pembrolizumab
measurable disease
Podillya Regional Center of Oncology ( Site 1708)
 (70.8 away) Contact site
  • 16 views
  • 27 Nov, 2020
  • +131 other locations
A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

The proposed study is a randomized, double-blind, placebo-controlled, multi-center Phase II study to investigate the safety and efficacy of SHR0302 in patients with moderate to severe active Crohn's Disease. The study aims to evaluate the optimal dose of SHR0302 and time needed in inducing clinical remission in active CD. This …

crohn's disease
remission
CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM
 (70.8 away) Contact site
  • 72 views
  • 19 Nov, 2020
  • +80 other locations